Lv4
800 积分 2024-12-17 加入
Effectiveness and safety of mono-anlotinib mono therapy or in combination with chemotherapy in platinum-resistant recurrent ovarian cancer: a single-center retrospective study
2个月前
已完结
Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A review
2个月前
已完结
First evidence of olaparib maintenance therapy in patients with newly diagnosed homologous recombination deficient positive/BRCA wild-type ovarian cancer: real-world multicenter study
3个月前
已完结
Chemo-surgical approach in vulvar leiomyosarcoma: A case report
10个月前
已完结
皖公网安备34019202002308
